You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intermediate and above per the Revised International Prognostic Scoring System (IPSS-R) groups

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Oral Azacitidine
  • Placebo for Oral Azacitidine
  • Buenos Aires, Argentina
  • +1 more
Aug 1, 2022

MDS and Allogeneic Stem Cell Transplantation Trial in Perugia (MDS and AlloHSCT)

Recruiting
  • MDS and Allogeneic Stem Cell Transplantation
  • MDS and AlloHSCT
  • Perugia, PG, Italy
    University of Perugia
Mar 11, 2021

MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Luspatercept
  • Epoetin Alfa
  • Concord, California
  • +100 more
Jul 20, 2023

MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Magrolimab
  • +2 more
  • Birmingham, Alabama
  • +168 more
Dec 7, 2022

MDS (MDS) Trial in United States (Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine)

Completed
  • Myelodysplastic Syndromes (MDS)
  • Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine
  • Chicago, Illinois
  • +11 more
Apr 4, 2022

MDS Trial in China, Japan (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
  • +33 more
Aug 16, 2022

MDS Trial (Imetelstat)

Available
  • Myelodysplastic Syndromes
  • (no location specified)
Jun 30, 2023

MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

Not yet recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Subcutaneous azacitidine
  • Oral decitabine/cedazuridine
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
May 29, 2023

Anemia in MDS Trial in Plantation, Bronx, Austin (TP-0184)

Completed
  • Anemia in Myelodysplastic Syndromes
  • Plantation, Florida
  • +2 more
Apr 4, 2022

MDS Trial in Worldwide (Luspatercept, Placebo)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Stanford, California
  • +73 more
Nov 19, 2021

MDS Trial in Miami, New York (50 gm CIVI/24 hours x 5 days every 4 week)

Recruiting
  • Myelodysplastic Syndromes
  • 50 gm CIVI/24 hours x 5 days every 4 week
  • Miami, Florida
  • +1 more
Jul 6, 2022

MDS, CMML Trial in Florence (CC-486)

Recruiting
  • MDS
  • CMML
  • Florence, Italy
    AOU Careggi- University of Florence
Mar 16, 2021

AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)

Not yet recruiting
  • AML/MDS
  • +2 more
  • (no location specified)
Aug 14, 2023

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Worcester, Massachusetts
  • +16 more
Oct 31, 2022

Brief Infant Sleep Questionnaire Revised (BISQ-R)

Not yet recruiting
  • Insomnia
  • Behavioral Insomnia of Childhood
    • (no location specified)
    Sep 21, 2022

    Myelofibrosis Trial in Worldwide (BMS-986158, Ruxolitinib, Fedratinib)

    Recruiting
    • Myelofibrosis
    • La Jolla, California
    • +36 more
    Jan 13, 2023

    GENOMED4ALL: Improving MDS Classification and Prognosis by AI

    Active, not recruiting
    • Myelodysplastic Syndromes
      • Milano, Italy
        Istituto Clinico Humanitas
      Jun 28, 2021

      Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post- Essential Thrombocythemia Myelofibrosis Trial in Worldwide

      Completed
      Has Results
      • Primary Myelofibrosis
      • +2 more
      • Phoenix, Arizona
      • +61 more
      May 5, 2022

      MDS, Iron Overload Trial in Stanford, Detroit, Houston (Deferasirox)

      Completed
      Has Results
      • Myelodysplastic Syndromes
      • Iron Overload
      • Stanford, California
      • +2 more
      Jun 1, 2021

      MDS Trial in Worldwide (MBG453, Placebo, Hypomethylating agents)

      Active, not recruiting
      • Myelodysplastic Syndromes
      • Duarte, California
      • +46 more
      Jan 20, 2023

      Ovarian Cancer Individualized Scoring System Scoring System

      Not yet recruiting
      • Ovarian Cancer
        • Alexandria, Egypt
        • +1 more
        Aug 9, 2022

        MDS Trial (Decitabine/Cedazuridine, Magrolimab)

        Not yet recruiting
        • Myelodysplastic Syndromes
        • (no location specified)
        Apr 18, 2023

        Trauma Severity Scores Injury Severity Score "ISS", Rapid

        Not yet recruiting
        • Polytrauma
          • (no location specified)
          Sep 15, 2022

          MDS Trial in Beijing (Hetrombopag, Stanozolol Tablets)

          Not yet recruiting
          • MDS
          • Beijing, China
            Peking Union Medical College Hospital
          Sep 18, 2021

          Philadelphia Negative Myeloproliferative Tumors Trial

          Not yet recruiting
          • Philadelphia Negative Myeloproliferative Neoplasms
            • (no location specified)
            Jun 5, 2022